Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

MGNXMACROGENICS INC

Nasdaq · CIK 0001125345
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts327

Identity from submissions API

NameMACROGENICS INC
CIK0001125345
TickersMGNX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone301-251-5172
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)1

Former names

  • None listed.
Business address
9704 MEDICAL CENTER DRIVE
Rockville
MD
20850
MD
Mailing address
9704 MEDICAL CENTER DRIVE
ROCKVILLE
MD
20850
MD

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

948 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005245 005-87928 261558050 34 10437
2026-11-13 8-K 8-K 7.01,9.01 0001125345-26-000077 001-36112 261554201 34 6057731 1 1
2026-11-12 8-K 8-K 2.02,9.01 0001125345-26-000074 001-36112 261547053 34 352345 1 1
2026-11-12 10-Q 10-Q 0001125345-26-000073 001-36112 261546885 34 6818525 1 1
2026-11-03 4 FORM 4 0001734755-26-000011 7668
2026-11-03 3 FORM 3 0001734755-26-000010 393323
2026-11-03 4 FORM 4 0001892413-26-000014 7631
2026-11-03 3 FORM 3 0001892413-26-000013 391404
2026-11-03 8-K 8-K 5.02,7.01,9.01 0001125345-26-000069 001-36112 261517729 34 181885 1 1
2026-10-23 8-K 8-K 8.01,9.01 0001125345-26-000066 001-36112 261482226 34 4055337 1 1
2026-10-22 144 xsl144X01/primary_doc.xml 0001628280-26-066897 001-36112 261479072 33 4436
2026-10-07 4 FORM 4 0001125345-26-000063 6993
2026-09-21 144 xsl144X01/primary_doc.xml 0001628280-26-062884 001-36112 261394062 33 5094
2026-09-03 S-8 S-8 0001125345-26-000062 333-298749 261359313 33 219328 1 1
2026-09-03 8-K/A 8-K/A 9.01 0001125345-26-000059 001-36112 261358922 34 410348 1 1
2026-08-20 4 FORM 4 0001706903-26-000006 5237
2026-08-19 144 xsl144X01/primary_doc.xml 0001628280-26-058022 001-36112 261296417 33 6939
2026-08-18 4 FORM 4 0001588365-26-000007 6996
2026-08-17 144 xsl144X01/primary_doc.xml 0001628280-26-057456 001-36112 261287749 33 5068
2026-08-14 10-Q 10-Q 0001125345-26-000056 001-36112 261282119 34 6724562 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003604 005-87928 261277261 34 10435
2026-08-13 8-K 8-K 2.02,9.01 0001125345-26-000054 001-36112 261273306 34 353209 1 1
2026-08-03 144 xsl144X01/primary_doc.xml 0001628280-26-051901 001-36112 261233430 33 6207
2026-08-03 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000070858-26-000403 005-87928 261233147 34 171481
2026-07-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002901 005-87928 261216907 34 10788
2026-07-23 8-K 8-K 8.01 0001125345-26-000050 001-36112 261197087 34 267505 1 1
2026-07-20 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-085111 005-87928 261187550 34 15794
2026-07-13 144 xsl144X01/primary_doc.xml 0001628280-26-048068 001-36112 261172411 33 4495
2026-07-08 8-K 8-K 5.02 0001125345-26-000047 001-36112 261162387 34 137420 1 1
2026-07-07 8-K 8-K 2.01,7.01,9.01 0001125345-26-000045 001-36112 261159626 34 461632 1 1
2026-06-05 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-071033 005-87928 261070137 34 15793
2026-05-20 4 FORM 4 0001140119-26-000002 11379
2026-05-20 4 FORM 4 0001566617-26-000002 11250
2026-05-20 4 FORM 4 0001214939-26-000002 11285
2026-05-20 4 FORM 4 0001722857-26-000002 6853
2026-05-20 4 FORM 4 0001324059-26-000002 11292
2026-05-20 4 FORM 4 0001534200-26-000003 11292
2026-05-20 4 FORM 4 0001211840-26-000002 11136
2026-05-20 4 FORM 4 0001191235-26-000002 11134
2026-05-20 4 FORM 4 0001598502-26-000002 11251
2026-05-20 4 FORM 4 0001587514-26-000009 7677
2026-05-20 8-K 8-K 5.07 0001125345-26-000042 001-36112 261003824 34 151910 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002170 005-87928 26984282 34 10431
2026-05-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-061374 005-87928 26980851 34 15507
2026-05-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000070858-26-000308 005-87928 26980585 34 171221
2026-05-13 8-K 8-K 2.02,9.01 0001125345-26-000040 001-36112 26973714 34 317188 1 1
2026-05-13 10-Q 10-Q 0001125345-26-000038 001-36112 26973410 34 5066747 1 1
2026-05-12 8-K 8-K 1.01,7.01,9.01 0001125345-26-000035 001-36112 26965923 34 1243907 1 1
2026-05-04 8-K 8-K 1.01,8.01,9.01 0001125345-26-000032 001-36112 26937357 34 363980 1 1
2026-04-22 DEFA14A DEFA14A 0001125345-26-000029 001-36112 26884417 34 110893
2026-04-08 8-K 8-K 8.01 0001125345-26-000026 001-36112 26848644 34 354139 1 1
2026-04-08 DEFA14A DEFA14A 0001125345-26-000022 001-36112 26848095 34 2190240
2026-04-08 DEF 14A DEF 14A 0001125345-26-000021 001-36112 26848088 34 6145439 1 1
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001810 005-87928 26802225 34 7080
2026-03-09 8-K 8-K 2.02 0001125345-26-000018 001-36112 26735064 34 419101 1 1
2026-03-09 10-K 10-K 0001125345-26-000017 001-36112 26735032 34 12048191 1 1
2026-03-02 8-K 8-K 8.01 0001125345-26-000011 001-36112 26707814 34 137359 1 1
2026-02-24 8-K 8-K 8.01 0001125345-26-000009 001-36112 26666933 34 354215 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001246 005-87928 26645092 34 10335
2026-02-17 4 FORM 4 0001588365-26-000005 12647
2026-02-17 4 FORM 4 0002051299-26-000005 12622
2026-02-17 4 FORM 4 0001587477-26-000005 12800
2026-02-17 4 FORM 4 0001706903-26-000004 12666
2026-02-17 4 FORM 4 0001675464-26-000004 12650
2026-02-17 4 FORM 4 0001587774-26-000004 12655
2026-02-17 4 FORM 4 0001587514-26-000007 6946
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001231919-26-000143 005-87928 26634797 34 30210
2026-02-10 4 FORM 4 0001587514-26-000004 6895
2026-02-10 4 FORM 4 0001675464-26-000002 13068
2026-02-10 4 FORM 4 0002051299-26-000002 13044
2026-02-10 4 FORM 4 0001587774-26-000002 13074
2026-02-10 4 FORM 4 0001706903-26-000002 13083
2026-02-10 4 FORM 4 0001587477-26-000002 13303
2026-02-10 4 FORM 4 0001588365-26-000002 13071
2026-01-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-001469 005-87928 26513514 34 9349
2025-12-10 4 FORM 4 0002051299-25-000004 5283
2025-11-20 8-K 8-K 5.02 0001125345-25-000111 001-36112 251502990 34 139692 1 1
2025-11-12 8-K 8-K 2.02 0001125345-25-000109 001-36112 251472566 34 440775 1 1
2025-11-12 10-Q 10-Q 0001125345-25-000108 001-36112 251472544 34 5586353 1 1
2025-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000814133-25-000105 005-87928 251472133 34 6406
2025-08-21 4 FORM 4 0001214939-25-000004 6660
2025-08-19 4 FORM 4 0001675464-25-000003 5305
2025-08-19 4 FORM 4 0001706903-25-000003 5323
2025-08-15 4 FORM 4 0001587514-25-000005 10508
2025-08-15 4 FORM 4 0001587774-25-000004 5309
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003602 005-87928 251222186 34 10588
2025-08-14 S-8 S-8 0001125345-25-000102 333-289603 251218996 33 222110 1 1
2025-08-14 10-Q 10-Q 0001125345-25-000101 001-36112 251218829 34 5660033 1 1
2025-08-14 8-K 8-K 2.02 0001125345-25-000100 001-36112 251218641 34 435042 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-021777 005-87928 251216686 34 35313
2025-08-13 8-K 8-K 5.02,7.01,9.01 0001125345-25-000094 001-36112 251211783 34 362416 1 1
2025-07-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-003225 005-87928 251132367 34 10752
2025-07-07 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-066208 005-87928 251109281 34 8837
2025-06-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-059293 005-87928 251045873 34 9357
2025-06-10 8-K 8-K 1.01,8.01,9.01 0001125345-25-000087 001-36112 251035923 34 359478 1 1
2025-05-22 4 FORM 4 0001125345-25-000084 13686
2025-05-22 4 FORM 4 0001125345-25-000083 11112
2025-05-22 4 FORM 4 0001125345-25-000082 11142
2025-05-22 4 FORM 4 0001125345-25-000081 10996
2025-05-22 4 FORM 4 0001125345-25-000080 11113
2025-05-22 4 FORM 4 0001125345-25-000079 11154
2025-05-22 4 FORM 4 0001125345-25-000078 10998
2025-05-22 4 FORM 4 0001125345-25-000077 13599
2025-05-22 4 FORM 4 0001125345-25-000076 11100
2025-05-22 8-K 8-K 5.07 0001125345-25-000075 001-36112 25976945 34 154146 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002266 005-87928 25951979 34 10590
2025-05-13 8-K 8-K 2.02 0001125345-25-000054 001-36112 25939855 34 419268 1 1
2025-05-13 10-Q 10-Q 0001125345-25-000053 001-36112 25939797 34 4526357 1 1
2025-04-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-035994 005-87928 25847162 34 15390
2025-04-11 DEFA14A DEFA14A 0001125345-25-000048 001-36112 25831504 34 2264098
2025-04-11 DEF 14A DEF 14A 0001125345-25-000047 001-36112 25831494 34 6160263 1 1
2025-03-20 8-K 8-K 2.02 0001125345-25-000043 001-36112 25756459 34 441730 1 1
2025-03-20 10-K 10-K 0001125345-25-000042 001-36112 25756439 34 9737471 1 1
2025-02-26 8-K 8-K 5.02 0001193125-25-036898 001-36112 25671336 34 145573 1 1
2025-02-19 4 FORM 4 0001125345-25-000037 6806
2025-02-19 4 FORM 4 0001125345-25-000036 8334
2025-02-19 4 FORM 4 0001125345-25-000035 6799
2025-02-19 4 FORM 4 0001125345-25-000033 8190
2025-02-19 4 FORM 4 0001125345-25-000032 8180
2025-02-19 4 FORM 4 0001125345-25-000031 8144
2025-02-19 4 FORM 4 0001125345-25-000030 8172
2025-02-19 4 FORM 4 0001125345-25-000029 8247
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-004293 005-87928 25631722 34 17017
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001316 005-87928 25631450 34 10617
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-013939 005-87928 25626980 34 8977
2025-02-11 4 FORM 4 0001125345-25-000020 389819
2025-02-11 4 FORM 4 0001125345-25-000019 395044
2025-02-11 4 FORM 4 0001125345-25-000018 393017
2025-02-11 4 FORM 4 0001125345-25-000017 391422
2025-02-11 4 FORM 4 0001125345-25-000016 12647
2025-02-11 4 FORM 4 0001125345-25-000015 389743
2025-02-11 4 FORM 4 0001125345-25-000013 395164
2025-02-11 4 FORM 4 0001125345-25-000012 390988
2025-02-11 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000814133-25-000017 005-87928 25611049 34 6536
2025-01-13 3 FORM 3 0001125345-25-000003 424330
2025-01-10 UPLOAD filename1.pdf 0000000000-25-000250 001-36112 39608
2025-01-03 CORRESP filename1.htm 0001193125-25-001480 47500
2024-12-03 UPLOAD filename1.pdf 0000000000-24-013305 001-36112 51783
2024-11-21 8-K 8-K 5.02 0001125345-24-000165 001-36112 241484917 34 150189 1 1
2024-11-20 SC 13G SC 13G 0001193125-24-262283 005-87928 241478668 34 325703
2024-11-14 SC 13G/A armistice-mgnx093024a2.htm 0001172661-24-005318 005-87928 241464240 34 90681
2024-11-08 SC 13G/A us5560991094_110824.txt 0002012383-24-003643 005-87928 241439796 34 13785
2024-11-05 8-K 8-K 2.02 0001125345-24-000161 001-36112 241427377 34 448056 1 1
2024-11-05 10-Q 10-Q 0001125345-24-000160 001-36112 241427363 34 5099621 1 1
2024-10-30 8-K 8-K 5.02,8.01,9.01 0001193125-24-247017 001-36112 241407469 34 162691 1 1
2024-10-22 SC 13G/A us5560991094_102224.txt 0002012383-24-001300 005-87928 241386124 34 13773
2024-10-09 4 FORM 4 0001125345-24-000155 6280
2024-09-25 4 FORM 4 0001125345-24-000153 6288
2024-09-16 8-K 8-K 8.01 0001125345-24-000151 001-36112 241301010 34 4361721 1 1
2024-08-06 8-K 8-K 2.02 0001125345-24-000149 001-36112 241179022 34 449333 1 1
2024-08-06 10-Q 10-Q 0001125345-24-000148 001-36112 241178966 34 4640772 1 1
2024-07-30 8-K 8-K 8.01 0001125345-24-000141 001-36112 241157682 34 371141 1 1
2024-07-30 8-K 8-K 8.01 0001125345-24-000140 001-36112 241157401 34 361090 1 1
2024-06-04 SC 13G MGNX_SC13G_June24.htm 0001273087-24-000075 005-87928 241019037 34 81671
2024-05-24 4/A FORM 4/A 0001125345-24-000136 5537
2024-05-23 4 FORM 4 0001125345-24-000134 7550
2024-05-23 4 FORM 4 0001125345-24-000133 10049
2024-05-23 4 FORM 4 0001125345-24-000132 7691
2024-05-23 4 FORM 4 0001125345-24-000131 9621
2024-05-23 4 FORM 4 0001125345-24-000130 7563
2024-05-23 4 FORM 4 0001125345-24-000129 7446
2024-05-23 4 FORM 4 0001125345-24-000128 7592
2024-05-23 4 FORM 4 0001125345-24-000127 7448
2024-05-23 4 FORM 4 0001125345-24-000126 7562
2024-05-23 8-K 8-K 5.07 0001125345-24-000124 001-36112 24978639 34 161159 1 1
2024-05-23 S-8 S-8 0001125345-24-000123 333-279674 24978604 33 102380
2024-05-22 4 FORM 4 0001125345-24-000109 6833
2024-05-22 4 FORM 4 0001125345-24-000108 6875
2024-05-22 4 FORM 4 0001125345-24-000107 6845
2024-05-22 4 FORM 4 0001125345-24-000106 6729
2024-05-22 4 FORM 4 0001125345-24-000105 6974
2024-05-22 4 FORM 4 0001125345-24-000104 6887
2024-05-22 4 FORM 4 0001125345-24-000103 6887
2024-05-22 4 FORM 4 0001125345-24-000102 6846
2024-05-22 4 FORM 4 0001125345-24-000101 6732
2024-05-21 SC 13G MGNX_SC13G_May24.htm 0001273087-24-000072 005-87928 24969477 34 81992
2024-05-09 8-K 8-K 2.02,9.01 0001125345-24-000091 001-36112 24930488 34 455093 1 1
2024-05-09 8-K 8-K 8.01,9.01 0001125345-24-000090 001-36112 24930406 34 3193886 1 1
2024-05-09 10-Q 10-Q 0001125345-24-000088 001-36112 24930327 34 4276340 1 1
2024-04-08 4 FORM 4 0001125345-24-000079 15733
2024-04-08 ARS ARS 0001125345-24-000078 001-36112 24830014 34 36812903
2024-04-08 DEFA14A DEFA14A 0001125345-24-000077 001-36112 24829999 34 7694626
2024-04-08 DEF 14A DEF 14A 0001125345-24-000076 001-36112 24829991 34 3711175
2024-04-04 144 xsl144X01/primary_doc.xml 0002002698-24-000086 001-36112 24823779 33 6541
2024-04-03 8-K 8-K 8.01,9.01 0001125345-24-000065 001-36112 24820204 34 377912 1 1
2024-03-08 4 FORM 4 0001125345-24-000063 11712
2024-03-07 8-K 8-K 2.02,9.01 0001125345-24-000061 001-36112 24729999 34 433527 1 1
2024-03-07 10-K 10-K 0001125345-24-000060 001-36112 24729983 34 16853036 1 1
2024-03-06 4 FORM 4 0001125345-24-000056 10157
2024-03-06 4 FORM 4 0001125345-24-000055 8304
2024-03-06 4 FORM 4 0001125345-24-000054 4775
2024-03-06 144 xsl144X01/primary_doc.xml 0002007317-24-000321 001-36112 24726093 33 5425
2024-03-04 144 xsl144X01/primary_doc.xml 0000103623-24-000035 001-36112 24716853 33 4389
2024-03-04 144 xsl144X01/primary_doc.xml 0002007317-24-000282 001-36112 24716673 33 4235
2024-03-04 144 xsl144X01/primary_doc.xml 0002007317-24-000277 001-36112 24716550 33 8947
2024-02-28 4 FORM 4 0001125345-24-000049 5114
2024-02-26 4 FORM 4 0001125345-24-000047 8175
2024-02-26 4 FORM 4 0001125345-24-000046 8162
2024-02-26 144 xsl144X01/primary_doc.xml 0002007317-24-000205 001-36112 24678954 33 4833
2024-02-20 4 FORM 4 0001125345-24-000043 8253
2024-02-20 4 FORM 4 0001125345-24-000041 8196
2024-02-20 4 FORM 4 0001125345-24-000040 8173
2024-02-20 4 FORM 4 0001125345-24-000039 8175
2024-02-20 4 FORM 4 0001125345-24-000038 8187
2024-02-20 4 FORM 4 0001125345-24-000037 8299
2024-02-20 4 FORM 4 0001125345-24-000036 8179
2024-02-20 4 FORM 4 0001125345-24-000035 8175
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-024002 005-87928 24640155 34 88531
2024-02-14 SC 13G/A armistice-mgnx123123a1.htm 0001172661-24-001230 005-87928 24636132 34 90658
2024-02-14 SC 13G mgnx13gdec23.txt 0001897612-24-001224 005-87928 34 6455
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-021390 005-87928 24628898 34 12992
2024-02-13 SC 13G/A SC 13G/A 0001193125-24-032794 005-87928 24622480 34 48564
2024-02-12 4 FORM 4 0001125345-24-000024 7704
2024-02-12 4 FORM 4 0001125345-24-000023 7667
2024-02-12 4 FORM 4 0001125345-24-000022 7662
2024-02-12 4 FORM 4 0001125345-24-000021 7674
2024-02-12 4 FORM 4 0001125345-24-000020 7684
2024-02-12 4 FORM 4 0001125345-24-000019 7657
2024-02-12 4 FORM 4 0001125345-24-000018 7662
2024-02-12 4 FORM 4 0001125345-24-000017 7774
2024-02-07 144 xsl144X01/primary_doc.xml 0002007317-24-000080 001-36112 24604626 33 5987
2024-02-07 4 FORM 4 0001125345-24-000008 4657
2024-02-07 4 FORM 4 0001125345-24-000007 13106
2024-02-05 144 xsl144X01/primary_doc.xml 0002007317-24-000066 001-36112 24595748 33 4241
2024-02-02 4 FORM 4 0001125345-24-000004 4769
2024-02-01 144 xsl144X01/primary_doc.xml 0002007317-24-000043 001-36112 24587011 33 5401
2024-01-24 SC 13G/A us5560991094_012424.txt 0001086364-24-002365 005-87928 24555929 34 13433
2024-01-22 4 FORM 4 0001125345-24-000002 4770
2024-01-19 144 xsl144X01/primary_doc.xml 0001971857-24-000089 001-36112 24545549 33 4814
2023-12-21 4 FORM 4 0001125345-23-000131 4773
2023-12-20 144 xsl144X01/primary_doc.xml 0002002698-23-000154 001-36112 231502114 33 4225
2023-11-15 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-11-15 16:00:00 9999999995-23-003335 333-275343 231412312 33 1664
2023-11-14 CORRESP filename1.htm 0001125345-23-000129 8457
2023-11-10 UPLOAD filename1.pdf 0000000000-23-012335 40154
2023-11-06 S-3 S-3 0001125345-23-000127 333-275343 231380049 33 705299
2023-11-06 8-K 8-K 2.02,9.01 0001125345-23-000125 001-36112 231379933 34 447943 1 1
2023-11-06 10-Q 10-Q 0001125345-23-000124 001-36112 231379924 34 5292772 1 1
2023-10-30 SC 13G SC 13G 0001104659-23-112608 005-87928 231360932 34 86567
2023-10-04 4 FORM 4 SUBMISSION 0000899243-23-019881 6310
2023-09-22 8-K 8-K 1.02 0001125345-23-000113 001-36112 231272219 34 154489 1 1
2023-09-11 4 FORM 4 SUBMISSION 0000899243-23-018688 6308
2023-09-01 4 FORM 4 0001125345-23-000111 4697
2023-08-09 8-K 8-K 2.02,9.01 0001125345-23-000109 001-36112 231155040 34 450618 1 1
2023-08-09 10-Q 10-Q 0001125345-23-000108 001-36112 231155022 34 5200304 1 1
2023-06-06 S-8 S-8 0001125345-23-000102 333-272451 23996184 33 363526
2023-06-02 4 FORM 4 0001125345-23-000100 7744
2023-06-02 4 FORM 4 0001125345-23-000099 7628
2023-06-02 4 FORM 4 0001125345-23-000098 7742
2023-06-02 4 FORM 4 0001125345-23-000097 7784
2023-06-02 4 FORM 4 0001125345-23-000096 7626
2023-06-02 4 FORM 4 0001125345-23-000095 7772
2023-06-02 4 FORM 4 0001125345-23-000094 10172
2023-06-02 4 FORM 4 0001125345-23-000093 10226
2023-06-02 4 FORM 4 0001125345-23-000092 7871
2023-06-02 8-K 8-K 5.07 0001125345-23-000081 001-36112 23986833 34 181842 1 1
2023-05-09 8-K 8-K 2.02,9.01 0001125345-23-000077 001-36112 23901902 34 446163 1 1
2023-05-09 10-Q 10-Q 0001125345-23-000076 001-36112 23901869 34 5334941 1 1
2023-04-27 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001140361-23-011892,2023-04-27 9999999995-23-001061 333-249851 23859780 33 1676
2023-04-19 DEFA14A DEFA14A 0001125345-23-000071 001-36112 23830087 34 1995157
2023-04-17 ARS 2022 ANN REPORT TO SHAREHOLDERS 0001125345-23-000069 001-36112 23823964 34 32603941
2023-04-17 DEFA14A DEFA14A 0001125345-23-000068 001-36112 23823952 34 2026526
2023-04-17 DEF 14A DEF 14A 0001125345-23-000067 001-36112 23823936 34 2287216
2023-03-24 8-K 8-K 8.01,9.01 0001125345-23-000063 001-36112 23760320 34 192550 1 1
2023-03-15 POS AM POS AM 0001140361-23-011892 333-249851 23736209 33 630021
2023-03-15 S-8 S-8 0001125345-23-000061 333-270562 23735391 33 99072
2023-03-15 10-K 10-K 0001125345-23-000059 001-36112 23735221 34 15906748 1 1
2023-03-15 8-K 8-K 2.02,9.01 0001125345-23-000058 001-36112 23735146 34 438843 1 1
2023-03-15 POSASR POSASR 0001140361-23-011814 333-249851 23735066 33 882334
2023-03-14 4 FORM 4 0001125345-23-000054 5031
2023-03-10 8-K 8-K 7.01 0001125345-23-000047 001-36112 23724250 34 164538 1 1
2023-03-09 8-K 8-K 1.01,8.01,9.01 0001125345-23-000045 001-36112 23718235 34 215571 1 1
2023-02-24 4 FORM 4 0001125345-23-000041 8128
2023-02-24 4 FORM 4 0001125345-23-000040 8110
2023-02-17 4 FORM 4 0001125345-23-000037 7622
2023-02-17 4 FORM 4 0001125345-23-000036 7632
2023-02-17 4 FORM 4 0001125345-23-000035 7627
2023-02-17 4 FORM 4 0001125345-23-000034 7649
2023-02-17 4 FORM 4 0001125345-23-000033 7639
2023-02-17 4 FORM 4 0001125345-23-000032 7629
2023-02-17 4 FORM 4 0001125345-23-000031 7626
2023-02-17 4 FORM 4 0001125345-23-000030 7709
2023-02-16 4 FORM 4 SUBMISSION 0000899243-23-005209 6276
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-039092 005-87928 23629169 34 55239
2023-02-14 SC 13G armistice-mgnx123122.htm 0001172661-23-001136 005-87928 23626145 34 90544
2023-02-14 SC 13G/A MACROGENICS, INC. 0000902664-23-001733 005-87928 23623902 34 61246
2023-02-14 8-K 8-K 8.01,9.01 0001125345-23-000021 001-36112 23620638 34 220182 1 1
2023-02-10 SC 13G/A mgnx223.txt 0000814133-23-000048 005-87928 23610337 34 3921
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-016403 005-87928 23603653 34 12911
2023-02-08 SC 13G/A MACROGENICS.txt 0000769993-23-000120 005-87928 23597408 34 23668
2023-01-24 SC 13G/A us5560991094_012423.txt 0001306550-23-003077 005-87928 23547483 34 13193
2023-01-23 4 FORM 4 SUBMISSION 0000899243-23-002378 6274
2023-01-18 SC 13G/A MGNX_SC13GA1_2023.htm 0001273087-23-000034 005-87928 23534653 34 81527
2023-01-05 4 FORM 4 0001125345-23-000019 5248
2023-01-05 3 FORM 3 0001125345-23-000018 7090
2023-01-05 4 FORM 4 0001125345-23-000017 5248
2023-01-05 3 FORM 3 0001125345-23-000016 7162
2023-01-05 8-K 8-K 5.02,7.01,9.01 0001125345-23-000011 001-36112 23509775 34 218602 1 1
2022-12-28 4 FORM 4 SUBMISSION 0000899243-22-039423 7803
2022-12-21 8-K 8-K 5.02 0001125345-22-000113 001-36112 221478553 34 167904 1 1
2022-12-16 8-K 8-K 1.01 0001125345-22-000111 001-36112 221468305 34 167044 1 1
2022-11-25 4 FORM 4 SUBMISSION 0000899243-22-036996 6278
2022-11-18 8-K 8-K 8.01,9.01 0001125345-22-000108 001-36112 221400083 34 203621 1 1
2022-11-03 10-Q 10-Q 0001125345-22-000104 001-36112 221357853 34 5059291 1 1
2022-11-03 8-K 8-K 2.02,9.01 0001125345-22-000103 001-36112 221357825 34 451623 1 1
2022-10-31 4 FORM 4 0001125345-22-000094 6706
2022-10-25 4 FORM 4 SUBMISSION 0000899243-22-034118 7806
2022-10-21 4 FORM 4 SUBMISSION 0000899243-22-033943 7805
2022-10-17 8-K 8-K 1.01,7.01,9.01 0001125345-22-000092 001-36112 221313952 34 241873 1 1
2022-09-02 SC 13G MGNX_Sept2022_SC13G.htm 0001273087-22-000105 005-87928 221225356 34 81492
2022-08-15 SC 13G/A SC 13G/A 0001104659-22-091314 005-87928 221166705 34 78752
2022-08-08 10-Q 10-Q 0001125345-22-000090 001-36112 221144289 34 4887106 1 1
2022-08-08 8-K 8-K 2.02,9.01 0001125345-22-000089 001-36112 221144260 34 458042 1 1
2022-07-08 8-K 8-K 8.01,9.01 0001125345-22-000080 001-36112 221075158 34 212033 1 1
2022-06-17 4 FORM 4 0001125345-22-000075 4935
2022-05-24 4 FORM 4 0001125345-22-000073 5233
2022-05-24 3 FORM 3 0001125345-22-000072 7109
2022-05-24 8-K 8-K 5.02,7.01,9.01 0001125345-22-000070 001-36112 22954086 34 215309 1 1
2022-05-23 4 FORM 4 0001125345-22-000068 5086
2022-05-23 4 FORM 4 0001125345-22-000067 7633
2022-05-23 4 FORM 4 0001125345-22-000066 7777
2022-05-23 4 FORM 4 0001125345-22-000065 5202
2022-05-23 4 FORM 4 0001125345-22-000064 5088
2022-05-23 4 FORM 4 0001125345-22-000063 7646
2022-05-23 8-K 8-K 5.07 0001125345-22-000053 001-36112 22952596 34 183039 1 1
2022-05-17 4 FORM 4 0001125345-22-000051 8086
2022-05-17 4 FORM 4 0001125345-22-000049 6849
2022-05-03 10-Q 10-Q 0001125345-22-000047 001-36112 22886763 34 4580165 1 1
2022-05-03 8-K 8-K 2.02,9.01 0001125345-22-000046 001-36112 22886746 34 443128 1 1
2022-04-08 DEFA14A DEFA14A 0001125345-22-000040 001-36112 22817045 34 2026526
2022-04-08 DEF 14A DEF 14A 0001125345-22-000039 001-36112 22817027 34 1879663
2022-03-28 4 FORM 4 0001125345-22-000036 6894
2022-03-04 4 FORM 4 0001125345-22-000034 6699
2022-02-24 4 FORM 4 0001125345-22-000032 5296
2022-02-24 4 FORM 4 0001125345-22-000031 5303
2022-02-24 4 FORM 4 0001125345-22-000030 7660
2022-02-24 4 FORM 4 0001125345-22-000029 5283
2022-02-24 4 FORM 4 0001125345-22-000028 5290
2022-02-24 4 FORM 4 0001125345-22-000027 5373
2022-02-24 4 FORM 4 0001125345-22-000026 5293
2022-02-24 4 FORM 4 0001125345-22-000025 7638
2022-02-24 S-8 S-8 0001125345-22-000016 333-262967 22671239 33 94302
2022-02-24 8-K 8-K 2.02,9.01 0001125345-22-000014 001-36112 22670948 34 450612 1 1
2022-02-24 10-K 10-K 0001125345-22-000013 001-36112 22670884 34 12229373 1 1
2022-02-14 SC 13G/A MACROGENICS INC 0001104659-22-022753 005-87928 22631937 34 89828
2022-02-14 SC 13G MACROGENICS, INC. 0000902664-22-001603 005-87928 22625769 34 67153
2022-02-11 SC 13G/A SC 13G/A 0001193125-22-037206 005-87928 22621838 34 51661
2022-02-11 SC 13G/A mgnx222.txt 0000814133-22-000044 005-87928 22617696 34 3927
2022-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-22-018017 005-87928 22610246 34 12908
2022-02-04 SC 13G MACROGENICS_INC.txt 0000769993-22-000127 005-87928 22592985 34 23425
2022-02-03 SC 13G/A us5560991094_020222.txt 0000834237-22-005267 005-87928 22585534 34 13338
2022-01-31 SC 13G/A SEC SCHEDULE 13G 0000914208-22-000069 005-87928 22572769 34 18052
2022-01-07 8-K 8-K 5.02 0001125345-22-000003 001-36112 22516074 34 168461 1 1
2021-11-23 4 FORM 4 SUBMISSION 0000899243-21-045703 6279
2021-11-16 4 FORM 4 0001125345-21-000117 6679
2021-11-02 10-Q 10-Q 0001125345-21-000115 001-36112 211371183 34 4891971 1 1
2021-11-02 8-K 8-K 2.02,9.01 0001125345-21-000114 001-36112 211371148 34 453704 1 1
2021-09-30 4 FORM 4 SUBMISSION 0000899243-21-038368 7809
2021-09-27 8-K 8-K 5.02 0001125345-21-000107 001-36112 211281870 34 171058 1 1
2021-09-20 4 FORM 4 SUBMISSION 0000899243-21-036543 7808
2021-09-16 8-K 8-K 8.01,9.01 0001125345-21-000105 001-36112 211258009 34 240286 1 1
2021-09-08 8-K 8-K 8.01,9.01 0001125345-21-000103 001-36112 211242259 34 218668 1 1
2021-07-29 8-K 8-K 2.02,9.01 0001125345-21-000100 001-36112 211127361 34 450854 1 1
2021-07-29 10-Q 10-Q 0001125345-21-000099 001-36112 211127346 34 5725518 1 1
2021-07-20 4 FORM 4 0001125345-21-000092 8737
2021-06-28 4 FORM 4 0001125345-21-000089 10076
2021-06-23 4 FORM 4 SUBMISSION 0000899243-21-025485 6278
2021-06-17 4 FORM 4 SUBMISSION 0000899243-21-024412 7808
2021-06-16 8-K 8-K 1.01,3.02,8.01,9.01 0001125345-21-000087 001-36112 211022124 34 214921 1 1
2021-06-11 SC 13G/A SC 13G/A 0001193125-21-189038 005-87928 211012395 34 55415
2021-06-11 3 FORM 3 SUBMISSION 0000899243-21-023294 5308
2021-05-18 4 FORM 4 0001125345-21-000084 8129
2021-05-18 4 FORM 4 0001125345-21-000083 9382
2021-05-18 8-K 8-K 5.07 0001125345-21-000082 001-36112 21936949 34 181736 1 1
2021-05-17 4 FORM 4 0001125345-21-000076 5088
2021-05-17 4 FORM 4 0001125345-21-000075 5192
2021-05-17 4 FORM 4 0001125345-21-000074 5204
2021-05-17 4 FORM 4 0001125345-21-000073 5090
2021-05-17 4 FORM 4 0001125345-21-000072 5229
2021-05-17 4 FORM 4 0001125345-21-000071 5205
2021-05-17 4 FORM 4 0001125345-21-000070 5228
2021-04-29 8-K FORM 8-K 8.01,9.01 0001140361-21-015000 001-36112 21871996 34 259928 1 1
2021-04-29 424B5 424B5 0001140361-21-014983 333-249851 21871539 33 403970
2021-04-29 8-K 8-K 2.02,9.01 0001125345-21-000061 001-36112 21870370 34 442185 1 1
2021-04-29 10-Q 10-Q 0001125345-21-000060 001-36112 21870347 34 4273503 1 1
2021-04-19 4 FORM 4 0001125345-21-000054 8736
2021-04-02 8-K 8-K 5.03,9.01 0001125345-21-000052 001-36112 21800106 34 354319 1 1
2021-04-02 DEFA14A DEFA14A 0001125345-21-000050 001-36112 21799902 34 9662978
2021-04-02 DEF 14A DEF 14A 0001125345-21-000049 001-36112 21799897 34 2735890
2021-03-24 4 FORM 4 0001125345-21-000042 4699
2021-03-24 4 FORM 4 0001125345-21-000040 4578
2021-03-10 SC 13G/A us5560991094_030921.txt 0000834237-21-007926 005-87928 21727366 34 13373
2021-03-09 4 FORM 4 0001125345-21-000038 8620
2021-02-25 S-8 S-8 0001125345-21-000036 333-253502 21680307 33 77653
2021-02-25 10-K 10-K 0001125345-21-000035 001-36112 21680263 34 15118788 1 1
2021-02-25 8-K 8-K 2.02,9.01 0001125345-21-000034 001-36112 21680202 34 286927 1 1
2021-02-24 4 FORM 4 0001125345-21-000029 5245
2021-02-24 4 FORM 4 0001125345-21-000028 5253
2021-02-24 4 FORM 4 0001125345-21-000027 5238
2021-02-24 4 FORM 4 0001125345-21-000026 5225
2021-02-24 4 FORM 4 0001125345-21-000025 5229

Latest XBRL company facts

One latest value per concept from companyfacts (327 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 63.91M 2026-11-06 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
dei EntityPublicFloat Entity Public Float USD 73.90M 2025-06-30 2025 FY 10-K 2026-03-09 0001125345-26-000017
ecd AwardExrcPrice AwardExrcPrice USD/shares 1.66 2025-08-13 DEF 14A 2026-04-08 0001125345-26-000021
ecd AwardGrantDateFairValue AwardGrantDateFairValue USD 913,000 2025-08-13 DEF 14A 2026-04-08 0001125345-26-000021
ecd AwardUndrlygSecuritiesAmt AwardUndrlygSecuritiesAmt securities 550,000 2025-08-13 DEF 14A 2026-04-08 0001125345-26-000021
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 730,744 2025-01-01 2025-12-31 DEF 14A 2026-04-08 0001125345-26-000021
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.19M 2025-01-01 2025-12-31 DEF 14A 2026-04-08 0001125345-26-000021
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 1.78M 2024-01-01 2024-12-31 DEF 14A 2026-04-08 0001125345-26-000021
ecd PeoTotalCompAmt PeoTotalCompAmt USD 6.40M 2024-01-01 2024-12-31 DEF 14A 2026-04-08 0001125345-26-000021
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 7.04 2025-01-01 2025-12-31 DEF 14A 2026-04-08 0001125345-26-000021
ecd UndrlygSecurityMktPriceChngPct UndrlygSecurityMktPriceChngPct pure -2 2025-08-13 DEF 14A 2026-04-08 0001125345-26-000021
ffd NetFeeAmt NetFeeAmt USD 695.68 2026-09-03 S-8 2026-09-03 0001125345-26-000062
ffd TtlFeeAmt TtlFeeAmt USD 695.68 2026-09-03 S-8 2026-09-03 0001125345-26-000062
ffd TtlOfferingAmt TtlOfferingAmt USD 5.04M 2026-09-03 S-8 2026-09-03 0001125345-26-000062
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-09-03 S-8 2026-09-03 0001125345-26-000062
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 3.14M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 435,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 2.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 26.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 95.81M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD -308,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 399.63M 2015-03-31 2015 Q1 10-Q 2015-05-06 0001125345-15-000013
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.31B 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.06M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 6.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 15.61M 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001125345-25-000108
us-gaap Assets Assets USD 318.69M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap AssetsCurrent Assets, Current USD 295.08M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 143.40M 2020-12-31 2020 FY 10-K 2021-02-25 0001125345-21-000035
us-gaap AssetsHeldForSaleNotPartOfDisposalGroup Assets Held-for-sale, Not Part of Disposal Group USD 0 2017-12-31 2018 FY 10-K 2019-02-26 0001125345-19-000046
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 308,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 238.96M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 89.28M 2019-12-31 2019 FY 10-K 2020-02-25 0001125345-20-000031
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 7.98M 2016-12-31 2017 FY 10-K 2018-02-27 0001125345-18-000022
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 7.99M 2016-12-31 2017 FY 10-K 2018-02-27 0001125345-18-000022
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 192.99M 2016-12-31 2017 FY 10-K 2018-02-27 0001125345-18-000022
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 192.90M 2016-12-31 2017 FY 10-K 2018-02-27 0001125345-18-000022
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 238.65M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap AvailableForSaleSecuritiesNoncurrent Available-for-sale Securities, Noncurrent USD 0 2017-12-31 2017 FY 10-K 2018-02-27 0001125345-18-000022
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 430,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 49.03M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 19.00M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -39.81M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-31 0001125345-19-000098
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 49.03M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -8.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 17.13M 2013-09-30 2013 Q3 10-Q 2013-11-12 0001193125-13-438247
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 125.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 2.12M 2013-09-30 2013 Q3 10-Q 2013-11-12 0001193125-13-438247
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 63.88M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap CommonStockSharesSubscribedButUnissued Common Stock, Shares Subscribed but Unissued shares 10.00M 2006-05-31 2013 Q3 10-Q 2013-11-12 0001193125-13-438247
us-gaap CommonStockValue Common Stock, Value, Issued USD 639,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -37.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ConstructionInProgressGross Construction in Progress, Gross USD 371,000 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap ContractualObligation Contractual Obligation USD 10.30M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 40.72M 2018-12-31 2019 FY 10-K 2020-02-25 0001125345-20-000031
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 55.50M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination USD 22.99M 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-25 0001125345-20-000031
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 9.59M 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-25 0001125345-20-000031
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001125345-16-000046
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 16.96M 2013-10-31 2014 Q3 10-Q 2014-11-12 0001193125-14-407501
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap CostsAndExpenses Costs and Expenses USD 130.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD -6.48M 2018-01-01 2019 FY 10-K 2020-02-25 0001125345-20-000031
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD -435,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD -672,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD -237,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 7.72M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap DeferredRentCredit Deferred Rent Credit USD 11.30M 2018-12-31 2018 FY 10-K 2019-02-26 0001125345-19-000046
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 0 2019-12-31 2019 FY 10-K 2020-02-25 0001125345-20-000031
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 0 2019-12-31 2019 FY 10-K 2020-02-25 0001125345-20-000031
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 10.92M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 55.50M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 35.11M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 417.82M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap DeferredTaxAssetsGrossNoncurrent Deferred Tax Assets, Gross, Noncurrent USD 1.60M 2014-12-31 2014 FY 10-K 2015-03-03 0001193125-15-075224
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 7.72M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 136.48M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 33.03M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 5.58M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 158,000 2022-12-31 2022 FY 10-K 2023-03-15 0001125345-23-000059
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsOther Deferred Tax Assets, Tax Credit Carryforwards, Other USD 33.82M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 78.95M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 15.84M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent USD 3.12M 2018-12-31 2018 FY 10-K 2019-02-26 0001125345-19-000046
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 410.10M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap DeferredTaxLiabilitiesGrossCurrent Deferred Tax Liabilities, Gross, Current USD 1.60M 2014-12-31 2014 FY 10-K 2015-03-03 0001193125-15-075224
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 394,952 2013-12-31 2013 FY 10-K 2014-03-20 0001193125-14-108048
us-gaap DeferredTaxLiabilitiesPrepaidExpenses Deferred Tax Liabilities, Prepaid Expenses USD 1.42M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2022-12-31 2022 FY 10-K 2023-03-15 0001125345-23-000059
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 2.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap Depreciation Depreciation USD 7.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap DepreciationAndAmortizationDiscontinuedOperations Depreciation and Amortization, Discontinued Operations USD 1.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 2.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax USD 96.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent Disposal Group, Including Discontinued Operation, Assets, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.58 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.9 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-04-29 0001125345-21-000060
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.58 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.009 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.16 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.027 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 18.60M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-26 0001125345-19-000046
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 7.90M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap EquitySecuritiesFvNiRealizedGainLoss Equity Securities, FV-NI, Realized Gain (Loss) USD -7.60M 2019-07-01 2019-09-30 2019 Q3 10-Q 2019-11-06 0001125345-19-000112
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001125345-16-000046
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD -353,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 25.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset Impaired Assets to be Disposed of by Method Other than Sale, Carrying Value of Asset USD 0 2021-12-31 2021 FY 10-K 2022-02-24 0001125345-22-000013
us-gaap ImpairedFinancingReceivableRelatedAllowance Impaired Financing Receivable, Related Allowance USD 0 2013-12-31 2013 FY 10-K 2014-03-20 0001193125-14-108048
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -132.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -132.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares -2.47 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001125345-21-000035
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -2.08 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -2.08 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent USD 95.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share USD/shares 1.5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share USD/shares 1.5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 12.07M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-25 0001125345-20-000031
us-gaap IncomeTaxReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Amount USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-28 0001125345-17-000041
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -15.81M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD -416,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD -225,605 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-20 0001193125-14-108048
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 2.02M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 388,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001125345-25-000042
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -237,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap IncomeTaxReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount USD 10.85M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-15 0001125345-23-000059
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -448,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -280,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities Increase (Decrease) in Accounts Payable and Other Operating Liabilities USD -640,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -1.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 4.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -2.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 13.40M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-26 0001125345-19-000046
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 1.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 264,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD -916,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -793,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -7,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 96,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -2.77M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap IncreaseDecreaseInRestrictedCashForOperatingActivities Increase (Decrease) in Restricted Cash for Operating Activities USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001125345-18-000022
us-gaap IncreaseDecreaseInRestructuringReserve Increase (Decrease) in Restructuring Reserve USD 0 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-06 0001125345-19-000112
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001125345-25-000108
us-gaap InterestExpense Interest Expense USD 13.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 8.51M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap InterestIncomeOther Interest Income, Other USD 3.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 960,000 2023-12-31 2024 FY 10-K 2025-03-20 0001125345-25-000042
us-gaap InventoryNet Inventory, Net USD 9.50M 2026-03-31 2026 Q1 10-Q 2026-05-13 0001125345-26-000038
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 608,000 2021-09-30 2021 Q3 10-Q 2021-11-02 0001125345-21-000115
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 3.10M 2023-12-31 2024 FY 10-K 2025-03-20 0001125345-25-000042
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 261,000 2023-12-31 2024 FY 10-K 2025-03-20 0001125345-25-000042
us-gaap InventoryWorkInProcessAndRawMaterials Inventory, Work in Process and Raw Materials USD 6.48M 2021-06-30 2021 Q2 10-Q 2021-07-29 0001125345-21-000099
us-gaap Investments Investments USD 238.65M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap LeaseCost Lease, Cost USD 6.36M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.123 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 65.30M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 33.36M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 5.51M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 6.42M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 6.35M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 7.41M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 6.26M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.62M 2019-09-30 2019 Q3 10-Q 2019-11-06 0001125345-19-000112
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 28.54M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap Liabilities Liabilities USD 293.53M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 318.69M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap LiabilitiesCurrent Liabilities, Current USD 107.23M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap LicenseAndServicesRevenue License and Services Revenue (Deprecated 2018-01-31) USD 4.50M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-07 0001125345-18-000058
us-gaap LicensesRevenue Licenses Revenue (Deprecated 2018-01-31) USD 42.02M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-12 0001193125-13-438247
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 60.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 119.64M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-31 0001125345-19-000098
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 14.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -80.61M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-31 0001125345-19-000098
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -82.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -78.84M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-31 0001125345-19-000098
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -37.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -38.31M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-03 0001193125-15-075224
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD 0.29 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-03 0001125345-16-000064
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -72.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap OperatingLeaseCost Operating Lease, Cost USD 6.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 36.76M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 5.19M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 29.67M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap OperatingLeasePayments Operating Lease, Payments USD 5.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 20.66M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 39.13M 2018-12-31 2018 FY 10-K 2019-02-26 0001125345-19-000046
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 6.32M 2018-12-31 2018 FY 10-K 2019-02-26 0001125345-19-000046
us-gaap OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals USD 1.10M 2018-12-31 2018 FY 10-K 2019-02-26 0001125345-19-000046
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 4.68M 2018-12-31 2018 FY 10-K 2019-02-26 0001125345-19-000046
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 4.87M 2018-12-31 2018 FY 10-K 2019-02-26 0001125345-19-000046
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 4.72M 2018-12-31 2018 FY 10-K 2019-02-26 0001125345-19-000046
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 4.76M 2018-12-31 2018 FY 10-K 2019-02-26 0001125345-19-000046
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 13.79M 2018-12-31 2018 FY 10-K 2019-02-26 0001125345-19-000046
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 6.99M 2017-09-30 2017 Q3 10-Q 2017-11-08 0001628280-17-011189
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 4.40M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-26 0001125345-19-000046
us-gaap OtherAssets Other Assets USD 295,000 2019-09-30 2019 Q3 10-Q 2019-11-06 0001125345-19-000112
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 709,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -340,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -121.39M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-06 0001125345-19-000112
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 175,000 2019-09-30 2019 Q3 10-Q 2019-11-06 0001125345-19-000112
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 258,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 656,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-09 0001125345-23-000076
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 5.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 6.06M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 1.47M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale USD 0 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-25 0001125345-21-000035
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities Other than Temporary Impairment Losses, Investments, Available-for-sale Securities USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-25 0001125345-20-000031
us-gaap ParticipatingSecuritiesDistributedAndUndistributedEarnings Participating Securities, Distributed and Undistributed Earnings (Deprecated 2014-01-31) USD 0 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-05 0001193125-14-295741
us-gaap ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic Participating Securities, Distributed and Undistributed Earnings (Loss), Basic USD 8.36M 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-03 0001193125-15-075224
us-gaap PaymentsForProceedsFromTenantAllowance Payments for (Proceeds from) Tenant Allowance USD 7.50M 2017-07-21 2018 FY 10-K 2019-02-26 0001125345-19-000046
us-gaap PaymentsForRestructuring Payments for Restructuring USD 298,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-07 0001125345-18-000058
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 223,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 263.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 5.49M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 8.74M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 119.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 83.80M 2013-10-16 2014 FY 10-K 2015-03-03 0001193125-15-075224
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 12.01M 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-20 0001193125-14-108048
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 141.00M 2015-07-01 2015-07-31 2017 FY 10-K 2018-02-27 0001125345-18-000022
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 159.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ProceedsFromSaleOfMachineryAndEquipment Proceeds from Sale of Machinery and Equipment USD 11,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap ProceedsFromSaleOfOtherProductiveAssets Proceeds from Sale of Other Productive Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 660,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -39.94M 2021-04-01 2021-06-30 2021 Q2 10-Q 2021-07-29 0001125345-21-000099
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 108.43M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 2.23M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 104.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 0 2015-12-31 2015 FY 10-K 2016-02-29 0001125345-16-000046
us-gaap RestructuringReserve Restructuring Reserve USD 0 2018-03-31 2018 Q1 10-Q 2018-05-07 0001125345-18-000058
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 0 2018-09-30 2018 Q3 10-Q 2018-11-07 0001125345-18-000097
us-gaap RestructuringReserveNoncurrent Restructuring Reserve, Noncurrent USD 0 2017-12-31 2017 FY 10-K 2018-02-27 0001125345-18-000022
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.28B 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 194,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-07 0001125345-18-000058
us-gaap Revenues Revenues USD 58.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001125345-22-000013
us-gaap RoyaltyIncomeNonoperating Royalty Income, Nonoperating USD 22.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-03 0001193125-15-075224
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 6.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 6.10M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions pure 0.05 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-12 0001193125-14-407501
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.67 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-03 0001125345-17-000057
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.023 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-03 0001125345-17-000057
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 545,970 2012-01-01 2012-12-31 2013 FY 10-K 2014-03-20 0001193125-14-108048
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 2.05M 2003-02-28 2013 FY 10-K 2014-03-20 0001193125-14-108048
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 8,171 2013-09-30 2013 Q3 10-Q 2013-11-12 0001193125-13-438247
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 1.59M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 8.65M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 12.92 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 343,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 2.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 1.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 3.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.63 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 8.70M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 12.90M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 9.75 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 8.12M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 12.53M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 9.93 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 5.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 2.74 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 14.9 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 4.25 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.96 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 21.35 2022-12-31 2022 FY 10-K 2023-03-15 0001125345-23-000059
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 6.69M 2022-12-31 2022 FY 10-K 2023-03-15 0001125345-23-000059
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 10.10M 2022-12-31 2022 FY 10-K 2023-03-15 0001125345-23-000059
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 18.58 2022-12-31 2022 FY 10-K 2023-03-15 0001125345-23-000059
us-gaap SharePrice Share Price USD/shares 37 2015-07-31 2017 FY 10-K 2018-02-27 0001125345-18-000022
us-gaap SharesIssued Shares, Issued shares 10.00M 2006-05-16 2013 FY 10-K 2014-03-20 0001193125-14-108048
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD -89,000 2023-07-01 2023-09-30 2023 Q3 10-Q 2023-11-06 0001125345-23-000124
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 25.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 25.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 3.52M 2015-07-01 2015-07-31 2017 FY 10-K 2018-02-27 0001125345-18-000022
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensation Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 249,374 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 1.86M 2013-01-01 2013-12-31 2015 FY 10-K 2016-02-29 0001125345-16-000046
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 1.04M 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 1.07M 2013-01-01 2013-12-31 2015 FY 10-K 2016-02-29 0001125345-16-000046
us-gaap SubleaseIncome Sublease Income USD 901,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap TreasuryStockNumberOfSharesHeld Treasury Stock, Number of Shares Held (Deprecated 2016-01-31) shares 0 2015-12-31 2015 FY 10-K 2016-02-29 0001125345-16-000046
us-gaap TreasuryStockRetiredCostMethodAmount Treasury Stock, Retired, Cost Method, Amount USD 0 2020-07-01 2020-09-30 2020 Q3 10-Q 2020-11-04 0001125345-20-000152
us-gaap TreasuryStockRetiredParValueMethodAmount Treasury Stock, Retired, Par Value Method, Amount USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001125345-21-000035
us-gaap TreasuryStockValue Treasury Stock, Value USD 0 2015-12-31 2015 FY 10-K 2016-02-29 0001125345-16-000046
us-gaap UndistributedEarningsAllocatedToParticipatingSecurities Undistributed Earnings Allocated to Participating Securities (Deprecated 2014-01-31) USD 0 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-05 0001193125-14-295741
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic USD 8.36M 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-03 0001193125-15-075224
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -293,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 8.34M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 5,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-25 0001125345-21-000035
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 398,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 337,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001125345-21-000035
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001125345-16-000046
us-gaap UnrecognizedTaxBenefitsResultingInNetOperatingLossCarryforward Unrecognized Tax Benefits Resulting in Net Operating Loss Carryforward (Deprecated 2014-01-31) USD 1.80M 2013-12-31 2013 FY 10-K 2014-03-20 0001193125-14-108048
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 8.30M 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap ValuationAllowancesAndReservesChargedToCostAndExpense SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense USD 2.04M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001125345-22-000013
us-gaap VariableLeaseCost Variable Lease, Cost USD 1.16M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001125345-26-000017
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 52,947 2012-12-31 2013 FY 10-K 2014-03-20 0001193125-14-108048
us-gaap WarrantsNotSettleableInCashFairValueDisclosure Warrants Not Settleable in Cash, Fair Value Disclosure USD 52,947 2012-12-31 2013 FY 10-K 2014-03-20 0001193125-14-108048
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 63.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 57.20M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-04-29 0001125345-21-000060
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 63.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001125345-26-000073

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →